TAVI.today
Home
Latest Developments
Treatment & Guidelines
Clinical Evidence
Resources
Sign-up to Newsletter
Language: English
Language: English
Deutsch
Italian
Spanish

TAVI.today

edwards-logo-2-1-1.svg

Clinical support material

Access a wealth of free resources for use in your clinical practice and supporting information for your patients. The materials come in many different formats from downloads and videos, to physical leaflets and models. All physical resources are currently available only for health care professionals in Europe, except France. Search below to find out more.

Resources

Access a wealth of free resources for use in your clinical practice and supporting information for your patients. The materials come in many different formats from downloads and videos, to physical leaflets and models. All physical resources are currently available only for health care professionals in Europe, except France. Search below to find out more.

Audience Type
Print
Edwards TAVI study compendium
In-depth summary of the key Edwards Lifescience TAVI studies.
Download
Print
PARTNER 3 Trial outcomes
PARTNER 3 Trial outcomes summary
Infographic comparing SAPIEN 3 TAVI with sAVR in patients with severe aortic stenosis at low surgical risk.
Download
USB
TAVI-procedural-animation-USB
TAVI procedural animation
Transfemoral approach for TAVI using balloon-expandable technology. Available to order as USB.
free
Video
Patient case study - Low risk frame 4
Patient case study - Low risk 74 year old
74 year old male patient with dyspnea, declining renal function and Parkinson disease.
Video
Patient case study - Low risk frame 2
Patient case study - High risk 72 year old
72 year old female patients with high BMI and severe aortic stenosis.
Video
Patient case study - Low risk frame 4
Patient case study - High risk 85 year old - previous sAVR
85 year old male patient with worsening dspnea, atrial fibrillation and stable declined pulmonary function.
Video
Patients with asymptomatic AS
Patients with asymptomatic AS
The importance of identifying and treating patients with asymptomatic aortic stenosis - Professor Prendergast.
Video
Durability of TAVI valves
Durability of TAVI valves
Current evidence on the durability of TAVI valves - Professor Möllmann.
PDF
Tavi durability overview
TAVI durability overview
A summary of the current durability data (up to 8 years) for TAVI valves.
Download
Video
Patient case study - Low risk frame 1
Patient case study - Low risk 81 year old
81 year old male patient with high BMI and a history of atrial fibrillation and prostate cancer - Dr Su-San Liem and Dr Jan Baan.
Video
How low risk AS patients differ from higher risk patients
How low risk AS patients differ from higher risk patients
How do low-risk aortic stenosis patients differ from patients with a higher risk score? Dr Maximilian Scherner.
Print
Aortic stenosis overview
Summarises the aetiology of aortic stenosis and its clinical evaluation, including the ESC/EACTS guidelines and treatment practices.
Download
PDF
Healthcare system benefits
A summary of the impact of TAVI on the healthcare system and hospital resources.
Download
Video
Euro Heart survery results
Euro Heart survey results
What are the biggest changes in the results between the Euro Heart survey 2 and 1? - Professor Lung.
Video
Improving the referral pathway in AS
Improving the referral pathway in AS
Impulse Study: improving the referral pathway in aortic stenosis - Professor Dr Tanja Rudolph.
Video
The role of the GC within the Heart team
The role of the GC within the Heart Team
Diagnoses and management of aortic stenosis - the role of the GC in the Heart Team - Dr Wood.
Video
QoL and clinical outcomes after TAVI
QoL and clinical outcomes after TAVI
Quality of life and clinical outcomes after sAVR and TAVI - Professor Hendrik Treede.
Video
Improvement of diagnosis & referral
Improvement of diagnosis & referral
Improvement of diagnoses and the referral pathway for aortic stenosis and GCs - Professor Dr Baumgartner.
Video
Diagnosis and referral best practice
Diagnosis and referral best practice
Best practices for diagnosing and referring patients for TAVI - Professor Dr Di Mario.
Video
Evolution of AS treatment
Evolution of AS treatment
The evolution of aortic stenosis treatment - Professor Dr Baumgartner.
Print
ESC/EACTS 2021 AS guideline flowchart
Graphic summary of the ESC/EACTS 2021 treatment guidelines.
Download

Stay informed with our newsletter

By providing your personal information, you agree to allow Edwards Lifesciences and its agents to use this information to communicate with you in the future, including information about services, events, and programs. Edwards Lifesciences and its agents will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Edwards Lifesciences and its agents, Edwards Lifesciences will use your information in accordance with the Edwards privacy policy.
Our monthly updates provide you the latest developments in TAVI and aortic stenosis.     Read more

Share this page on:

Facebook Twitter Linkedin Envelope
Latest Developments

Treatment & Guidelines

Clinical Evidence
Resources

Contact Edwards

Sitemap
Privacy Policy

Legal Terms

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable). Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, PARTNER, PARTNER II, PARTNER 3, SAPIEN, and SAPIEN 3 are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

© 2023 Edwards Lifesciences Corporation. All rights reserved. PP--EU-0778  v1.0
Stäng filmen

Help us create better content with 3 short questions.

Content relating to Tavi.today is intended for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.
OK
Skip to content